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A B S T R A C T
Dilated cardiomyopathy is a delayed-onset and rarely reported cardiac complication of burn injury
although the mechanism remains unclear. We thus report a case of dilated cardiomyopathy following
severe burn injury, in which technetium 99m sestamibi single-photon emission computed tomography
(SPECT), iodine-123 beta-methyl-iodophenylpentadecanoic acid SPECT and 18F-ﬂuorodeoxyglucose
positron emission tomography (PET) were performed to evaluate the pathophysiologic condition in
combination with cardiac catheterization and myocardial biopsy. The cardiac PET and SPECT images
showed reduced myocardial blood ﬂow, decreased fatty acid metabolism, and increased glucose
utilization in the left ventricular lateral wall in spite of normal coronary angiography, no signiﬁcant
cardiac ﬁbrosis, and inﬂammatory cell inﬁltration, which suggests that myocardial ischemia due to
microcirculatory disturbance in hypermetabolic state associated with burn injury might be a causative
mechanism of dilated cardiomyopathy in this case. A beta blocker, bisoprolol, was successfully
introduced in this patient in combination with oral inotropic agents, pimobendan and digitalis after the
prolonged use of intravenous dobutamine infusion, which might have been beneﬁcial for this patient
with burn-associated dilated cardiomyopathy not only to reduce regional myocardial ischemia but also
to attenuate hypermetabolic state after severe burn injury.
<Learning objective: Dilated cardiomyopathy complicated with burn injury has been reported to cause
a sudden attack of dyspnea and death. This case report suggests that burn-associated dilated
cardiomyopathy may be caused by relative myocardial ischemia due to microvascular disturbance in
hypermetabolic state associated with burn injuries and can be treated effectively with beta blockers with
or without oral inotropic agents.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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been reported as a delayed-onset (42–310 days after the onset of
burn injury) and rarely reported cardiac complication of burn
injury which causes a sudden attack of dyspnea and death [2–4],
the condition is poorly recognized and the pathophysiology
remains largely unclear. Cardiac positron emission tomography
(PET) and single-photon emission computed tomography (SPECT)
are noninvasive techniques to assess myocardial blood ﬂow, fatty
acid metabolism, and glucose utilization [5–7]. We thus report a
case of dilated cardiomyopathy following severe burn injury, ins reserved.
Fig. 1. The chest X-ray on the 1st day (A) and 111th day (B) of admission.
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pathophysiologic condition in combination with cardiac catheter-
ization and myocardial biopsy.
Case report
A 51-year-old male was transferred to our hospital for burn
injury resulting from a suicide attempt. He had a history of
depression but not that of any cardiac diseases. He showed no sign
of heart failure on chest X-ray on admission (Fig. 1A). The extent of
burn was 60% of his total body surface area. Since inhalation injury
was also found, tracheostomy was performed for respiratory care.
Burns were treated with a series of debridement and skin-grafting
operations. Echocardiography showed preserved left ventricular
(LV) ejection fraction of 56% and LV diastolic diameter of 52 mm on
the 71st day of admission.
Sudden onset of decrease in arterial oxygen saturation occurred
on the 106th day of admission. Chest X-ray showed severe
pulmonary inﬁltrative shadow in both sides (Fig. 1B) and B-type
natriuretic peptide level was 1027 pg/ml. Echocardiography
showed severe LV global hypokinesis with ejection fraction of
25% and LV diastolic diameter of 52 mm. LV wall was neither
edematous nor hyperechoic and pericardial effusion was not
identiﬁed on echocardiography. Cardiac enzyme levels were
normal and ST-segment elevation or depression in electrocardio-
gram was not observed. The patient was diagnosed as having heart
failure and intravenous infusion of dobutamine and milrinone was
initiated. However, the intravenous infusion of the inotropes could
not be tapered off due to the repetition of the exacerbation of heart
failure. Cardiac catheterization including myocardial biopsy was
performed on the 189th day of admission while intravenous
infusion of dobutamine was continued. These studies showed
global LV hypokinesis with ejection fraction of 24% (Fig. 2A and B)
and oxygen saturation of mixed venous blood ﬂow (SvO2) of 55.7%
in spite of no signiﬁcant coronary artery stenosis (Fig. 2C and D)
and preserved cardiac index of 2.86 and 3.36 l/min/m2 measured
by thermo- and Fick’s methods, respectively. Pulmonary artery
pressure, pulmonary capillary wedge pressure and LV end-
diastolic pressure were 21/9 mmHg, 7 mmHg, and 17 mmHg,
respectively. No signiﬁcant intercellular ﬁbrosis and inﬂammatory
cell inﬁltration were observed in myocardial biopsy samples
obtained from the interventricular septum. Intravenous infusion of
inotropes was able to be ceased on the 224th day of admission and
bisoprolol was successfully introduced after the initiation of theoral administration of pimobendan and digitalis. His symptoms
were gradually relieved and he was transferred to another hospital
for rehabilitation on the 310th day of admission. Follow-up
echocardiography on the 401st day of admission showed that LV
systolic function was recovered with an ejection fraction of 49%
and LV end-diastolic diameter of 40 mm.
We performed technetium 99m sestamibi (99mTc-MIBI) SPECT,
iodine-123 beta-methyl-iodophenylpentadecanoic acid SPECT and
18F-ﬂuorodeoxyglucose (18F-FDG) PET under fasting conditions to
assess the cause of heart failure on the 244th day, 239th day, and
241st day of admission, respectively. Although no signiﬁcant
stenosis was observed in coronary angiography, 99mTc-MIBI–
SPECT demonstrated a decrease in myocardial blood ﬂow in the LV
lateral wall (Fig. 3A), where decreased fatty acid metabolism and
increased glucose utilization were observed in the area using
BMIPP SPECT and 18F-FDG-PET, respectively (Fig. 3B and C). These
ﬁndings indicate that myocardial ischemia may be associated with
the cause of dilated cardiomyopathy in this case.
Discussion
To the best of our knowledge, this is the ﬁrst case that burn-
associated dilated cardiomyopathy was investigated using cardiac
PET and SPECT. Although neither signiﬁcant coronary stenosis,
cardiac ﬁbrosis, nor inﬂammatory-cell inﬁltration was found in
coronary angiography and myocardial biopsy, reduced myocardial
blood ﬂow, decreased fatty acid metabolism, and increased glucose
utilization were observed in this case. These ﬁndings have also been
reported in some cases of idiopathic dilated cardiomyopathy [5–7]
and may be caused by endothelial dysfunction and/or decreased
angiogenesis [8]. Reduced myocardial blood ﬂow and coronary
endothelial dysfunction were also observed in animal models of
burn injuries [9,10]. Therefore, relative myocardial ischemia due to
microcirculatory disturbance in hypermetabolic state might have
caused burn-associated dilated cardiomyopathy in this case.
LV systolic function was globally decreased although decreased
myocardial blood ﬂow and fatty acid metabolism and increased
glucose utilization were localized to the lateral wall in this case.
Such a discrepancy has also been observed in the past reports of
idiopathic dilated cardiomyopathy [5–7]. Histological analysis and
cardiac magnetic resonance imaging, respectively, showed patchy
and variable ﬁbrosis and late gadolinium enhancement in the area
with decrease in myocardial blood ﬂow and glucose utilization in
idiopathic dilated cardiomyopathy [7,11]. These ﬁndings suggest
Fig. 2.
The end-diastolic (A) and end-systolic (B) phases of the left ventricle and the left (C) and right (D) coronary artery shown by the cardiac catheterization on the
189th day of admission.
Fig. 3.
Technetium 99m sestamibi single-photon emission computed tomography (SPECT) (A), 18F-ﬂuorodeoxyglucose positron emission tomography (B) and iodine-
123 beta-methyl-iodophenylpentadecanoic acid SPECT (C) on the 244th day, 239th day, and 241st day of admission, respectively.
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cardiomyopathy may reﬂect the process of cardiac damage. On the
other hand, global myocardial blood ﬂow is relatively more
homogenous and local defect of myocardial blood ﬂow is moderate
in idiopathic dilated cardiomyopathy compared to ischemic heart
disease [6], which can explain that regional abnormality of cardiac
metabolism and myocardial blood ﬂow is not associated with
corresponding wall motion abnormality.Several animal studies showed acute impairment of cardiac
contraction as early as 2 h postburn, which gradually resolved at
48–72 h [12]. The early reversibility indicated that acute cardiac
dysfunction occurred in burn injury. In contrast, dilated cardio-
myopathy was delayed-onset (42–310 days after the onset of burn
injury) [2–4] and required a year to recover in this case. Myocardial
microvascular remodeling has been reported to occur in patients
with idiopathic dilated cardiomyopathy [13] and to be induced by
R. Fukui et al. / Journal of Cardiology Cases 10 (2014) 180–183 183tumor necrosis factor-alpha [14], which is increased in patients
with burn injury [15]. Therefore, an anatomical basis such as
myocardial microvascular remodeling might explain the delayed-
onset and slow recovery of dilated cardiomyopathy in burn injury.
It was difﬁcult to taper off intravenous inotropes in this patient
without the administration of oral inotropic agents, which was
probably related to the low SvO2 despite preserved cardiac index.
Long-term treatment with beta blockers has been shown to
ameliorate impaired regional myocardial blood ﬂow in idiopathic
dilated cardiomyopathy [16], and may attenuate hypermetabolic
response induced by catecholamine surge in burn injury [17], and
thus may also be effective for burn-associated dilated cardiomy-
opathy. Burn injury elicits high cardiac output [18] that probably
compensates for the hypermetabolic state in burn injury [19].
Therefore, inotropic agents may be necessary to effectively support
this hypermetabolic condition, and combination therapy with a
beta blocker and inotropic agents should be considered in burn-
associated dilated cardiomyopathy.
In conclusion, this case suggests that burn-associated dilated
cardiomyopathy may be caused by relative myocardial ischemia
due to microvascular disturbance in the hypermetabolic state
associated with burn injuries and can be treated effectively with
beta blockers with or without oral inotropic agents.
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